Validate gene findings before telling donors

摘要

You report on recommendations that US biobanks should make participants in genome studies aware of incidental findings about their own DNA that might be medically relevant (Nature 483,373 and 387; 2012). But assigning participants access rights to research that is not validated could be putting the cart before the horse.